{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:14:05Z","timestamp":1791810845904,"version":"4.3.4"},"reference-count":58,"publisher":"Impact Journals, LLC","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,25]]},"DOI":"10.18632\/oncotarget.15100","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T22:21:23Z","timestamp":1486506083000},"page":"50098-50108","source":"Crossref","is-referenced-by-count":42,"title":["Predictable biomarkers of developing lymphoma in patients with Sj\u00f6gren syndrome: a nationwide population-based cohort study"],"prefix":"10.18632","volume":"8","author":[{"given":"Yu-Hsiang","family":"Chiu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology\/Immunology\/Allergies, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hsiang","family":"Chung","sequence":"additional","affiliation":[{"name":"School of Public Health, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuen-Tze","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Sheng","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Cheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology\/Immunology\/Allergies, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Yeong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Periodontology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Tsung","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Cheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology\/Immunology\/Allergies, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Chien","family":"Chien","sequence":"additional","affiliation":[{"name":"School of Public Health, National Defense Medical Center, Taipei, Taiwan"},{"name":"Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,4]]},"reference":[{"key":"1","first-page":"450","article-title":"Rate, risk factors and causes of mortality in patients with Sjogren's syndrome: a systematic review and meta-analysis of cohort studies","volume":"55","author":"Matteson","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study","volume":"50","author":"Jacobsson","year":"2004","journal-title":"Arthritis Rheum"},{"key":"3","first-page":"kew194","article-title":"Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sj\u00f6gren syndrome: analysis of 515 patients","author":"De Vita","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","article-title":"Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients","volume":"53","author":"Valesini","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","article-title":"Prognosis and outcome of non-Hodgkin lymphoma in primary Sjogren syndrome","volume":"91","author":"Moutsopoulos","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome","volume":"70","author":"Jonsson","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","article-title":"Risk, predictors, and clinical characteristics of lymphoma development in primary Sjogren's syndrome","volume":"41","author":"Vilardell-Tarres","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s10875-011-9553-3","article-title":"Active immunological profile is associated with systemic Sjogren's syndrome","volume":"31","author":"Hatron","year":"2011","journal-title":"J Clin Immunol"},{"key":"9","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Spinelli","year":"2008","journal-title":"Blood"},{"key":"10","first-page":"2376","article-title":"Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjogren's syndrome","volume":"24","author":"Valsecchi","year":"1997","journal-title":"J Rheumatol"},{"key":"11","first-page":"287","article-title":"Sjogren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma","volume":"64","author":"Zoumbos","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"key":"12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0002-9343(64)90101-9","article-title":"THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN's SYNDROME","volume":"36","author":"Bunim","year":"1964","journal-title":"Am J Med"},{"key":"13","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Moutsopoulos","year":"2005","journal-title":"Arch Intern Med"},{"key":"14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.1780390508","article-title":"Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren's syndrome","volume":"39","author":"Moutsopoulos","year":"1996","journal-title":"Arthritis Rheum"},{"key":"15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Adami","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome","volume":"29","author":"Moutsopoulos","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mpo.2950200403","article-title":"Lymphoma in Sjogren's syndrome","volume":"20","author":"Moutsopoulos","year":"1992","journal-title":"Med Pediatr Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/rheumatology\/kei281","article-title":"Incidence of cancer in a cohort of patients with primary Sjogren's syndrome","volume":"45","author":"Isenberg","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1018472213872","article-title":"Elevated incidence of hematologic malignancies in patients with Sjogren's syndrome compared with patients with rheumatoid arthritis (Finland)","volume":"8","author":"Isomaki","year":"1997","journal-title":"Cancer Causes Control"},{"key":"20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Chused","year":"1978","journal-title":"Ann Intern Med"},{"key":"21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects","volume":"88","author":"Moutsopoulos","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/annrheumdis-2011-200402","article-title":"Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan","volume":"71","author":"Lu","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","article-title":"A longitudinal cohort study of Finnish patients with primary Sjogren's syndrome: clinical, immunological, and epidemiological aspects","volume":"60","author":"Pasternack","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/38.3.245","article-title":"Primary Sjogren's syndrome in the North East of England: a long-term follow-up study","volume":"38","author":"Griffiths","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(98)80040-1","article-title":"Predictors of lymphoma development in primary Sjogren's syndrome","volume":"28","author":"Isenberg","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/kem079","article-title":"Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors","volume":"46","author":"Font","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","article-title":"Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome","volume":"44","author":"Font","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome","volume":"46","author":"Moutsopoulos","year":"2002","journal-title":"Arthritis Rheum"},{"key":"29","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sjogren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren's Syndrome","volume":"42","author":"Moutsopoulos","year":"1999","journal-title":"Arthritis Rheum"},{"key":"30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0049-0172(96)80019-9","article-title":"Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome","volume":"25","author":"Talal","year":"1996","journal-title":"Semin Arthritis Rheum"},{"key":"31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","article-title":"Biomarkers of lymphoma in Sjogren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study","volume":"51","author":"Colafrancesco","year":"2014","journal-title":"J Autoimmun"},{"key":"32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Weisman","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome","volume":"109","author":"Gordon","year":"2002","journal-title":"J Clin Invest"},{"key":"34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","article-title":"Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases","volume":"44","author":"Stohl","year":"2001","journal-title":"Arthritis Rheum"},{"key":"35","unstructured":"National Health Insurance Administration MoHaW, Taiwan, R.O.C. 2015. National Health Insurance in Taiwan 2015-2016 Annual Report."},{"key":"36","doi-asserted-by":"crossref","first-page":"e2097","DOI":"10.1097\/MD.0000000000002097","article-title":"Inverse Association of Parkinson Disease With Systemic Lupus Erythematosus: A Nationwide Population-based Study","volume":"94","author":"Kao","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"37","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/jamainternmed.2015.3540","article-title":"Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database","volume":"175","author":"Ioannidis","year":"2015","journal-title":"JAMA Intern Med"},{"key":"38","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Jaffe","year":"2016","journal-title":"Blood"},{"key":"39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semarthrit.2013.04.004","article-title":"Malignant lymphoma in primary Sjogren's syndrome: an update on the pathogenesis and treatment","volume":"43","author":"Voulgarelis","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"40","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0092-8674(00)80373-6","article-title":"ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death","volume":"90","author":"Rajewsky","year":"1997","journal-title":"Cell"},{"key":"41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.immuni.2007.05.010","article-title":"The transcriptional regulation of B cell lineage commitment","volume":"26","author":"Kee","year":"2007","journal-title":"Immunity"},{"key":"42","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(00)05185-0","article-title":"Pathways for self-tolerance and the treatment of autoimmune diseases","volume":"357","author":"Goodnow","year":"2001","journal-title":"Lancet"},{"key":"43","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"Tedder","year":"2008","journal-title":"Blood"},{"key":"44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell","volume":"6","author":"Hiepe","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"45","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/eji.200939633","article-title":"Tolerance checkpoints in B-cell development: Johnny B good","volume":"39","author":"Rolink","year":"2009","journal-title":"Eur J Immunol"},{"key":"46","doi-asserted-by":"crossref","first-page":"e5456","DOI":"10.1371\/journal.pone.0005456","article-title":"Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells","volume":"4","author":"Rolink","year":"2009","journal-title":"PLoS One"},{"key":"47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1074-7613(04)00079-2","article-title":"Reduced Competitiveness of Autoantigen-Engaged B Cells due to Increased Dependence on BAFF","volume":"20","author":"Cyster","year":"2004","journal-title":"Immunity"},{"key":"48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Schneider","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2006.04.004","article-title":"BAFF, APRIL and human B cell disorders","volume":"18","author":"Good","year":"2006","journal-title":"Semin Immunol"},{"key":"50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2010.00944.x","article-title":"B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor","volume":"237","author":"Hibbs","year":"2010","journal-title":"Immunol Rev"},{"key":"51","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/ni.1666","article-title":"Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling","volume":"9","author":"Cancro","year":"2008","journal-title":"Nat Immunol"},{"key":"52","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1002\/eji.200838618","article-title":"B-cell responses to B-cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta","volume":"38","author":"Turner","year":"2008","journal-title":"Eur J Immunol"},{"key":"53","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.autrev.2015.07.002","article-title":"Anti-SSA\/SSB-negative Sjogren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution","volume":"14","author":"Bombardieri","year":"2015","journal-title":"Autoimmun Rev"},{"key":"54","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/modpathol.2009.131","article-title":"Immunomodulator agent-related lymphoproliferative disorders","volume":"22","author":"O'Malley","year":"2009","journal-title":"Mod Pathol"},{"key":"55","article-title":"Cancer Recurrence Following Immune-suppressive Therapies in Patients With Immune-mediated Diseases: a Systematic Review and Meta-analysis","author":"Ananthakrishnan","year":"2016","journal-title":"Gastroenterology"},{"key":"56","first-page":"S680","volume-title":"The American College of Rheumatology and the Association of Rheumatology Health Professionals 2012 Annual Meeting","author":"Hyrich","year":"2012"},{"key":"57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology Classification Criteria for Sj\u00f6gren's Syndrome: A Data-Driven, Expert Consensus Approach in the SICCA Cohort","volume":"64","author":"Heidenreich","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","article-title":"New Treatment Guidelines for Sjogren's Disease","volume":"42","author":"Hammitt","year":"2016","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T20:38:08Z","timestamp":1589143088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,4]]},"references-count":58,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2017,7,25]]}},"alternative-id":["15100","28177920"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15100","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,4]]}}}